Andreas Kluge
Founder bei TELIX PHARMACEUTICALS LIMITED
Vermögen: 191 Mio $ am 31.03.2024
Aktive Positionen von Andreas Kluge
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Director/Board Member | 03.01.2017 | - |
| Founder | 01.11.2015 | - | |
| Chief Tech/Sci/R&D Officer | 03.01.2017 | 02.06.2020 | |
Therapeia GmbH & Co. Kg
 Therapeia GmbH & Co. Kg Pharmaceuticals: MajorHealth Technology Therapeia GmbH & Co. Kg provides diagnostic and therapeutic radiopharmaceuticals. The firm offers treatment for brain cancer. The company was founded by Andreas Kluge in 2007 and is headquartered in Dresden, Germany. | Chief Executive Officer | 01.01.2007 | - |
| Founder | 01.01.2007 | - | |
| Chief Tech/Sci/R&D Officer | 01.01.2007 | - | |
| ABX-CRO advanced pharmaceutical services | Chief Tech/Sci/R&D Officer | 01.08.2002 | - |
| Founder | 01.08.2002 | - |
Karriereverlauf von Andreas Kluge
Ehemalige bekannte Positionen von Andreas Kluge
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
ABX advanced biochemical compounds GmbH
 ABX advanced biochemical compounds GmbH Chemicals: SpecialtyProcess Industries Part of Otsuka Holdings Co., Ltd., ABX advanced biochemical compounds GmbH is a German company that manufactures chemicals for nuclear medicine applications. The private company is based in Radeburg, Germany. The company was founded by Andreas Kluge. Andreas Kluge has been the CEO since incorporation. ABX advanced biochemical compounds was acquired by Cambridge Isotope Laboratories, Inc. on September 20, 2006. | Chief Executive Officer | 01.09.1996 | 01.07.2002 |
| Founder | 01.09.1996 | 01.07.2002 |
Ausbildung von Andreas Kluge
| Freie Universität Berlin | Doctorate Degree |
Statistik
International
| Deutschland | 5 |
| Australien | 2 |
Operativ
| Founder | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Chief Executive Officer | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TELIX PHARMACEUTICALS LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
ABX advanced biochemical compounds GmbH
ABX advanced biochemical compounds GmbH Chemicals: SpecialtyProcess Industries Part of Otsuka Holdings Co., Ltd., ABX advanced biochemical compounds GmbH is a German company that manufactures chemicals for nuclear medicine applications. The private company is based in Radeburg, Germany. The company was founded by Andreas Kluge. Andreas Kluge has been the CEO since incorporation. ABX advanced biochemical compounds was acquired by Cambridge Isotope Laboratories, Inc. on September 20, 2006. | Process Industries |
Therapeia GmbH & Co. Kg
Therapeia GmbH & Co. Kg Pharmaceuticals: MajorHealth Technology Therapeia GmbH & Co. Kg provides diagnostic and therapeutic radiopharmaceuticals. The firm offers treatment for brain cancer. The company was founded by Andreas Kluge in 2007 and is headquartered in Dresden, Germany. | Health Technology |
| ABX-CRO advanced pharmaceutical services |
- Börse
- Insiders
- Andreas Kluge
- Erfahrung
